As of April 25, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum ...

Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 7.25%, which has investors questioning if this is right time ...

The Trump administration initiated investigations into computer chips, semiconductor equipment, and pharmaceuticals imports under Section 232, citing national security concerns. These probes aim ...

StockNews.com assumed coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a sell rating on ...

President Donald Trump says he plans to impose tariffs on pharmaceuticals "very shortly," in what could be the next phase of his sweeping overhaul of global trade. President Donald Trump says he ...

President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..

Since 2020, U.S. imports of Chinese pharmaceuticals — defined by the U.S. tariff code to include packaged medicaments, vaccines, blood, organic cultures, bandages, and organs — have grown by ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Phathom Pharmaceuticals (PHAT – Research Report), Nkarta (NKTX – Research Repo ...